Number of Patients Exhibiting Natural Killer Cell Expansion [clinicaltrials_resource:NCT00625729/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Number of Patients Exhibiting Natural Killer Cell Expansion [clinicaltrials_resource:NCT00625729/outcome/1]
Bio2RDF identifier
NCT00625729/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00625729/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
Correlation of interleukin-15 ...... Natural Killer Cell expansion.
Only patients who responded to treatment included in the analysis.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
type [clinicaltrials_vocabulary:type]
alternate
Number of Patients Exhibiting Natural Killer Cell Expansion
@en
identifier
clinicaltrials_resource:NCT00625729/outcome/1
title
Successful natural killer (NK) ...... in the mononuclear population.
@en
type
label
Number of Patients Exhibiting ...... esource:NCT00625729/outcome/1]
@en